TP53 and breast carcinoma: Intrinsic alterations like PIK3 catalytic subunit α mutations (PIK3CA-mut) and tumor protein p53 gene mutations (TP53-mut) occur in approximately 30% to 40% of ER+ breast cancers and confer poor prognosis and treatment resistance (24–36).